Second Conjoint Meeting of RIKEN and ISM

It is a great pleasure to welcome you to The University of Tokyo for the Second Conjoint RIKEN–ISM Targeting Microbiota Meeting.

Over these two days, scientists, clinicians and innovators from Japan and around the world come together around a central question: how can we move microbiota science from observation to mechanism, and from mechanism to meaningful intervention? Read More

Abstracts Book & Agenda 2026

RIKEN-ISM Tokyo Meeting 2026 Speakers

RIKEN Center Director Prof. Masayuki Amagai to Open the 2nd Joint RIKEN–ISM 2026

Prof. Masayuki Amagai, MD, PhD, Director of the RIKEN Center for Integrative Medical Sciences and Professor of Dermatology at Keio University School of Medicine, will deliver the opening remarks at the 2nd Joint RIKEN–ISM Targeting Microbiota 2026, taking place on September 24–25, 2026, at The University of Tokyo.

Nature Portfolio, Yakult and ISM Join Forces in Tokyo to Connect Global Funding with Japanese Microbiome Research

ISM–RIKEN Tokyo 2026 Digital Pass

The Final Agenda Is Here: The Microbiota World Meets in Tokyo

RIKEN-ISM Tokyo Meeting 2026 Confirmed Speakers

Opening Remarks: 2nd Conjoint RIKEN–ISM Targeting Microbiota 2026

Masayuki Amagai, Center Director, RIKEN Center for Integrative Medical Sciences (IMS), Japan

Gut Microbes, Tryptophan Metabolism, and Pulmonary Hypertension: A Targetable Gut–Lung Axis

Yoshikazu Nakaoka, National Cerebral and Cardiovascular Center Research Institute, Japan

Microbial Metabolites as Drivers of Gastric Mucosal Defense

Naoko Satoh-Takayama, RIKEN Center for Integrative Medical Sciences (IMS), Japan

Microbiota-Metabolite Control of Cardiac Injury and Repair

Patrick C.H. Hsieh, Institute of Biomedical Sciences, Academia Sinica, Taiwan

The Microbiota–Muscle Axis in Aging: How Trimethylamine N-Oxide (TMAO) Remodels Mitochondria and Promotes Sarcopenia

Ippei Shimizu, National Cerebral and Cardiovascular Center Research Institute, Japan

Single-Cell Ramanomics Platform Enables Rapid Probiotic Quality Assessment and Strain Traceability

Jian Xu, Qingdao Institute of BioEnergy and Bioprocess Technology - CAS, China

Living Probiotics, Microbial Metabolites, and Mitochondrial Resilience: A Pathway to Healthy Aging

Dongryeol Ryu, Gwangju Institute of Science and Technology (GIST), Korea

Strain and Function-Resolved Metagenomics to Identify Microbial Drivers of Chronic Disease

Wataru Suda, RIKEN Center for Integrative Medical Sciences (IMS), Japan

Precision Microbiome Therapeutics to Enhance Cancer Immunotherapy

Sin-Hyeog Im, Pohang University of Science and Technology (POSTECH), Korea

Concluding Remarks: 2nd Conjoint RIKEN–ISM Targeting Microbiota 2026

Hiroshi Ohno, RIKEN Center for Integrative Medical Sciences (IMS), Japan

Who is Attending RIKEN-ISM Tokyo Meeting 2026

Academia Sinica, Taiwan
AJINOMOTO CO., INC., Japan
alma Inc., Japan
Bhabha Atomic Research Centre, India
Bird Healing, Japan
Colorado State University, United States
Dongshin University, South Korea
Fujita Health University, Japan
Gastro Solutions, Mexico
Gwangju Institute of Science and Technology (GIST), South Korea
Hospital Universitario de A Coruña, Spain
Immunology Frontier Research Center, The University of Osaka, Japan
INSERM, France
Institute of Science Tokyo, Japan
Jeonbuk National University, South Korea
Kolmar Korea, South Korea
Kyoto University, Japan
Lewis Katz School of Medicine at Temple University, United States
Mahidol University, Thailand
Medical University of Warsaw, Poland
Meiji Holdings Co., Ltd., Japan
Morinomiya University of Medical Sciences, Japan
National Agriculture and Food Research Organization (NARO), Japan
National Cerebral and Cardiovascular Center Research Institute, Japan
National Cheng Kung University, Taiwan
National Defense Medical University, Taiwan
National Institute of Genetics, Japan
National Taiwan University, Taiwan
Novonesis, Japan
Oklahoma State University, United States
Peking University, China
Pohang University of Science and Technology (POSTECH), South Korea
Qingdao Institute of BioEnergy and Bioprocess Technology, China
Queensland University of Technology (QUT), Australia
RIKEN Center for Integrative Medical Sciences (IMS), Japan
RMIT University, Australia
Samsung Medical Center, South Korea
Seoul National University, South Korea
Shenzhen People’s Hospital, China
Taizhou Changxin Biotechnology Co., Ltd., China
The University of Osaka, Japan
The University of Tokyo, Japan
The University of Tokyo, IQB, Japan
Universidad de Magallanes, Chile
University of California, Riverside, United States
University of Saint Joseph, Macao
University of the Ryukyus, Japan
Virginia Commonwealth University, United States
Waseda University, Japan

Updated till 20th September, 2026…